Omitel D Capsule is a combination pharmaceutical formulation containing Domperidone 10 mg and Omeprazole 20 mg, designed to manage gastrointestinal disorders characterized by acid reflux and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Omeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, leading to prolonged reduction of gastric acidity. The synergistic action of these two agents makes Omitel D Capsule effective in treating conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, peptic ulcers, and dyspepsia associated with delayed gastric emptying. It is typically prescribed to alleviate symptoms including heartburn, acid regurgitation, and epigastric discomfort. Omitel D Capsule should be used under medical supervision, with dosage adjusted according to the severity of the condition and patient response. Caution is advised in patients with underlying cardiac conditions or hepatic impairment. Adverse effects may include headache, dry mouth, and abdominal cramps. Regular monitoring is recommended to ensure therapeutic efficacy and safety.